Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes

Clinical Science

Volumn 112, Issue 11-12, 2007, Pages 599-606

  Song, Fangfang ^a   Jia, Wenbo ^a   Yao, Ying ^b   Hu, Yafei ^a   Lei, Lin ^a   Lin, Jie ^a   Sun, Xiufa ^a   Liu, Liegang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antioxidant; Comet assay; DNA damage; Glucose tolerance; Impaired glucose regulation; Oxidative stress; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; COMET ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ERYTHROCYTE; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPOTHESIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL;

ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DNA; DNA DAMAGE; ERYTHROCYTES; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 34249812373     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060323     Document Type: Article

References (46)

1. Rathmann, W. and Giani, G. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 2568-2569
2. American Diabetes Association. (2000) Type 2 diabetes in children and adolescents (consensus statement). Diabetes Care 23, 381-389
3. King, H., Aubert, R. E. and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431
4. Weyer, C., Bogardus, C., Mott, D. M. and Pratley, R. E. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J. Clin. Invest. 104, 787-794
5. Stumvoll, M., Goldstein, B. J. and van, Haeften, T. W. (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346
6. Ferrannini, E., Gastaldelli, A., Miyazaki, Y. et al. (2003) Predominant role of reduced β-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46, 1211-1219
7. Gorogawa, S., Kajimoto, Y., Umayahara, Y. et al. (2002) Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57, 1-10
8. Schinner, S., Scherbaum, W. A., Bornstein, S. R. and Barthel, A. (2005) Molecular mechanisms of insulin resistance. Diabetic Med. 22, 674-682
9. Rao, S. S., Disraeli, P. and McGregor, T. (2004) Impaired glucose tolerance and impaired fasting glucose. Am. Fam. Physician 69, 1961-1968
10. Unwin, N., Shaw, J., Zimmet, P. and Alberti, K. G. (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med. 19, 708-723
11. Baron, A. D. (2001) Impaired glucose tolerance as a disease. Am. J. Cardiol. 88, 16H-9H
12. Rosen, P., Nawroth, P. P., King, G., Moller, W., Tritschler, H. J. and Packer, L. (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17, 189-212
13. Bonnefont-Rousselot, D., Bastard, J. P., Jaudon, M. C. and Delattre, J. (2000) Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 26, 163-176
14. Ruhe, R. C. and McDonald, R. B. (2001) Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J. Am. Coll. Nutr. 20, S363-S369
15. Guerrero-Romero, F. and Rodriguez-Moran, M. (2005) Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch. Med. Res. 36, 250-257
16. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
17. Hanson, R. L., Pratley, R. E., Bogardus, C. et al. (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am. J. Epidemiol. 151, 190-198
18. Beuege, J. A. and Aust, S. D. (1978) Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310
19. Beutler, E., Duron, O. and Kelly, B. M. (1963) Improved method for determination of blood glutathione. J. Lab. Clin. Med. 61, 882-888
20. Kono, Y. (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186, 189-195
21. Benzie, I. F. and Strain, J. J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assav. Anal. Biochem. 239, 70-76
22. Singh, N. P., McCov, M. T., Tice, R. R. and Schneider, E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191
23. Tice, R. R., Andrews, P. W. and Singh, N. P. (1990) The single cell gel assay: a sensitive technique for evaluating intercellular differences in DNA damage and repair. Basic Life Sci. 53, 291-301
24. Olive, P. L., Banath, J. P. and Durand, R. E. (1990) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res. 122, 86-94
25. Rahimi, R., Nikfar, S., Larijani, B. and Abdollahi, M. (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother. 59, 365-373
26. Bhatia, S., Shukla, R., Venkata Madhu, S., Kaur Gambhir, J. and Madhava Prabhu, K. (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin. Biochem. 36, 557-562
27. Komosinska-Vassev, K., Olczyk, K., Olczyk, P. and Winsz-Szczotka, K. (2005) Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res. Clin. Pract. 68, 207-216
28. Saha, A., Adak, S., Chowdhury, S. and Bhattacharyya, M. (2005) Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clin. Chim. Acta 361, 141-149
29. Seghrouchni, I., Drai, J., Bannier, E. et al. (2002) Oxidative stress parameters in type I, II and insulin-treated type 2 diabetes mellitus: insulin treatment efficiency. Clin. Chim. Acta 321, 89-96
30. Kesavulu, M. M., Rao, B. K., Giri, R., Vijaya, J., Subramanyam, G. and Apparao, C. (2001) Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res. Clin. Pract. 53, 33-39
31. Kesavulu, M. M., Giri, R., Rao, B. K. and Apparao, C. (2000) Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 26, 387-392
32. Arai, K., Iizuka, S., Tada, Y., Oikawa, K. and Taniguchi, N. (1987) Increase in glycosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glycosylation with the enzyme activity. Biochim. Biophys. Acta 924, 292-296
33. Dincer, Y., Akcay, T., Alademir, Z. and Ilkova, H. (2002) Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat. Res. 505, 75-81
34. Opara, E. C., Abdel-Rahman, E., Soliman, S. et al. (1999) Depletion of total antioxidant capacity in type 2 diabetes. Metab. Clin. Exp. 48, 1414-1417
35. King, G. L. and Loeken, M. R. (2004) Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell Biol. 122, 333-338
36. Zeigler, D., Sohr, C. G. and Nourooz-Zadeh, J. (2004) Oxidative stress and antioxidant defense in relation to severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 27, 2178-2183
37. Choi, S. W., Benzie, I. F. and Lam, C. S. (2005) Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabetic Med. 22, 1347-1353
38. Pitozzi, V., Giovannelli, L., Bardini, G., Rotella, C. M. and Dolara, P. (2003) Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat. Res. 529, 129-133
39. Dandona, P., Thusu, K., Cook, S. et al. (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347, 444-445
40. Leinonen, J., Lehtimaki, T., Toyokuni, S. et al. (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417, 150-152
41. Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A. and Toyota, T. (1999) Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42, 995-998
42. Collins, A. R., Cadet, J., Moller, L., Poulsen, H. E. and Vina, J. (2004) Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch. Biochem. Biophys. 423, 57-65
43. ESCODD (European Standards Committee on Oxidative DNA Damage). (2002) Comparative analysis of baseline 8-oxo-7,8-dinydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 23, 2129-2133
44. Blasiak, J., Arabski, M. and Krupa, R. (2004) DNA damage and repair in type 2 diabetes mellitus. Mutat. Res. 554, 297-304
45. Anderson, D., Yu, T. W., Wright, J. and Ioannides, C. (1998) An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat. Res. 398, 151-156
46. Hannon-Fletcher, M. P., O'Kane, M. J., Moles, K. W., Weatherup, C., Barnett, C. R. and Barnett, Y. A. (2000) Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat. Res. 460, 53-60